Lyka Labs Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
|
|
|
|
|
|
|
|
|
Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 | Mar '2020 | |
---|---|---|---|---|---|
SOURCES OF FUNDS : | |||||
Equity Share Capital | 34.17 | 31.77 | 29.47 | 29.40 | 29.33 |
Reserves | 57.17 | 28.30 | 15.75 | -24.28 | -9.91 |
Equity Share Warrants | 9.07 | 17.44 | 0.00 | 0.00 | 0.00 |
Equity Application Money | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Shareholders Funds | 100.41 | 77.51 | 45.22 | 5.12 | 19.42 |
Secured Loans | 19.47 | 3.34 | 3.78 | 151.37 | 126.88 |
Unsecured Loans | 38.23 | 69.68 | 124.49 | 10.58 | 9.35 |
Total Debt | 57.70 | 73.02 | 128.27 | 161.95 | 136.23 |
Other Liabilities | 2.89 | 2.99 | 4.65 | 12.22 | 21.46 |
Total Liabilities | 161.00 | 153.52 | 178.14 | 179.29 | 177.11 |
APPLICATION OF FUNDS : | |||||
Gross Block | 156.00 | 153.59 | 171.88 | 162.94 | 140.52 |
Less: Accumulated Depreciation | 100.36 | 88.07 | 81.76 | 67.60 | 38.87 |
Less:Impairment of Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Block | 55.64 | 65.52 | 90.12 | 95.34 | 101.65 |
Lease Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capital Work in Progress | 23.05 | 16.23 | 17.74 | 24.40 | 26.40 |
Investments | 32.42 | 32.41 | 32.41 | 32.41 | 32.41 |
Current Assets, Loans & Advances | |||||
Inventories | 9.56 | 6.94 | 8.18 | 4.30 | 5.71 |
Sundry Debtors | 25.73 | 17.16 | 17.59 | 9.90 | 6.59 |
Cash and Bank Balance | 5.89 | 8.70 | 15.38 | 6.53 | 8.40 |
Loans and Advances | 8.67 | 9.49 | 6.03 | 5.00 | 9.99 |
Total Current Assets | 49.85 | 42.29 | 47.19 | 25.73 | 30.69 |
Less : Current Liabilities and Provisions | |||||
Current Liabilities | 19.66 | 20.18 | 25.24 | 32.46 | 42.24 |
Provisions | 1.49 | 1.17 | 1.02 | 1.62 | 1.91 |
Total CL & Provisions | 21.16 | 21.35 | 26.25 | 34.08 | 44.15 |
Net Current Assets | 28.69 | 20.94 | 20.93 | -8.35 | -13.46 |
Miscellaneous Expenses not written off | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Assets | 0.00 | 0.00 | 0.00 | 16.22 | 12.28 |
Deferred Tax Liability | 3.73 | 3.99 | 4.12 | 0.00 | 0.00 |
Net Deferred Tax | -3.73 | -3.99 | -4.12 | 16.22 | 12.28 |
Other Assets | 24.92 | 22.41 | 21.06 | 19.28 | 17.83 |
Total Assets | 161.00 | 153.52 | 178.14 | 179.29 | 177.11 |
Contingent Liabilities | 23.10 | 24.49 | 31.00 | 20.56 | 28.00 |